871266-61-4

Basic information

• Product Name: 4-benzyloxy-N-tert-butyl-3-iodobenzenesulfonamide
• Synonyms: 4-benzyloxy-N-tert-butyl-3-iodobenzenesulfonamide
• CAS NO: 871266-61-4
• Molecular Weight: 445.321
• Mol File: 871266-61-4.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 4-benzyloxy-N-tert-butyl-3-iodobenzenesulfonamide(CAS DataBase Reference)
• NIST Chemistry Reference: 4-benzyloxy-N-tert-butyl-3-iodobenzenesulfonamide(871266-61-4)
• EPA Substance Registry System: 4-benzyloxy-N-tert-butyl-3-iodobenzenesulfonamide(871266-61-4)

Safety Data

• Hazardous Substances Data: 871266-61-4(Hazardous Substances Data)

Upstream product

• 871266-60-3 4-benzyloxy-3-iodobenzenesulfonic acid 
• 871266-62-5 sodium 4-benzyloxy-3-iodobenzenesulfonate 
• 121208-93-3 4-hydroxy-3-iodobenzenesulfonic acid 
• 100-39-0 benzyl bromide 
• 533-58-4 2-Iodophenol 
• 75-64-9 tert-butylamine 

Downstream Products

• 871266-68-1 (6,2'-bisbenzyloxy-5'-N-tert-butylsulfamoyl-5-formylbiphenyl-3-yl)acetic acid methyl ester 
• 871266-67-0 dibenzyl (S)-2-{2-[5-(5-carbamimidoyl-1H-benzimidazol-2-yl)-6,2'-dihydroxy-5'-sulfamoylbiphenyl-3-yl]acetylamino}succinate 
• 871266-69-2 [6,2'-bis-benzyloxy-5'-N-tert-butylsulfamoyl-5-(5-carbamimidoyl-1H-benzimidazolyl-2-yl)biphenyl-3-yl]acetic acid methyl ester hydrochloride 
• 1597414-61-3 (R)-2-{2-[5-(5-carbamimidoyl-1H-benzimidazol-2-yl)-6,2'-dihydroxy-5'-sulfamoylbiphenyl-3-yl]acetylamino}succinic acid hydrochloride 
• 1597414-60-2 C₄₀H₃₆N₆O₉S*ClH 
• 1597414-62-4 C₄₀H₃₆N₆O₉S*ClH 
• 1597414-59-9 C₂₂H₁₉N₅O₆S*ClH 
• 1597414-58-8 C₄₀H₃₉N₅O₆S*ClH 
• 1597414-57-7 C₃₃H₃₃NO₇S 

Relevant articles and documents

FACTOR VIIA INHIBITOR

The present invention relates to novel inhibitors of Factors VIIa, IXa, Xa, XIa, in particular Factor VIIa, pharmaceutical compositions comprising these inhibitors, and methods for using these inhibitors for treating or preventing thromboembolic disorders, cancer or rheumatoid arthritis. Processes for preparing these inhibitors are also disclosed.

FACTOR VIIA INHIBITOR

The present invention relates to novel inhibitors of Factors VIIa, IXa, Xa, XIa, in particular Factor VIIa, pharmaceutical compositions comprising these inhibitors, and methods for using these inhibitors for treating or preventing thromboembolic disorders